UNAIDS. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update. December1998
2.
RaviglioneMCSniderDEKochiA. Global epidemiology of Tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA1995; 273: 220–226.
3.
World Health Organization. Tuberculosis - a global emergency: case notification update. February1996. Global Tuberculosis programme, World Health Organization, WHO/TB/96.197.
4.
RaviglioneMCHarriesADMsiskaRWilkinsonDNunnP. Tuberculosis and HIV: current status in Africa. AIDS1997; 11 (suppl B): S115–S123.
5.
Treatment of Tuberculosis: Guidelines for National Programmes. Second Edition1997. World Health Organization. Global Tuberculosis Programme. WHO/TB/97.220.
6.
RaviglioneMCDyeCSchmidtSKochiA; for the WHO Global Surveillance and Monitoring Project. Assessment of worldwide tuberculosis control. Lancet1997; 350: 624–629
7.
Global Tuberculosis Control, WHO Report 1998 World Health Organization, Global Tuberculosis Programme. WHO/TB/98.237.
8.
NyanguluDSHarriesADKang'OmbeCTuberculosis in a prison population in Malawi. Lancet1997; 350: 1284–87.
9.
PorterJKesslerC. Tuberculosis in refugees: a neglected dimension of the “global epidemic of tuberculosis” Trans Roy Soc Trop Med Hyg1995; 89: 241–42.
10.
HarriesADNyirendaTEBanerjeeABoereeMJSalaniponiFM. Tuberculosis in health care workers in Malawi. Trans Roy Soc Trop Med Hyg1999; 93: 32–35.
11.
WilkinsonDPillayMDaviesGRMolecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health1997; 2: 747–53.
12.
GilksCFGodfrey-FaussettPBatchelorBIFRecent transmission of tuberculosis in a cohort of HIV-1 infected female sex workers in Nairobi, Kenya. AIDS1997; 11: 911–18.
13.
MaherDHauslerHPRaviglioneMCTuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. Int J Tuberc Lung Dis1997; 1: 276–83.
14.
WilkinsonD.High-compliance tuberculosis treatment programme in a rural community. Lancet1994; 343: 647–48
15.
MurrayCJLDejongheEChumHJCost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet1991; 338: 1305–1308.
16.
HarriesADNyanguluDSKang'OmbeCTreatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodefiency virus serostatus in Zomba hospital, Malawi. Trans Roy Soc Trop Med Hyg1998; 92: 343–47.
17.
PalellaFJ, DelaneyKM, MoormanACDeclining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Eng J Med1998; 338: 853–60.
18.
MocroftAVellaSBenfieldTLChanging patterns of mortality across Europe in patients infected with HIV-1. Lancet1998; 352: 1725–1730.
19.
Sassan-MorrokoM, WiktorSZ, AbouyaLSignificant reduction in mortality attributable to cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Ivory Coast. 12th World AIDS Conference Geneva, 1998. Conference Supplement, page 5–6. Late Breakers Poster Abstracts 12461 Ab No.
20.
LawnSDShattockRJGriffinGE. Delays in the diagnosis of tuberculosis: a great new cost. Int J Tuberc Lung Dis1997; 1: 48586.
21.
SalaniponiFMLKwanjanaJNyasuluILoss of tuberculosis officers from a national tuberculosis programme: the Malawi experience, 1993 – 1997. Int J Tuberc Lung Dis1999; 3: 174–175.
22.
Pablos-MendezA, RaviglioneMC, LaszloAGlobal surveillance for antituberculosis-drug resistance, 1994 – 1997. N Eng J Med1998; 338: 1641–1649.
23.
KenyonTAMwasekagaMJHuebnerRLow levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis1999; 3: 4–11.
24.
WilkinsonD, SquireSB, GarnerP.Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. Br Med J1998; 317: 625–29.
25.
AisuT, RaviglioneM, van PraagEPreventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS1995; 9.267–273.